MDGL - Madrigal Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

MDGL is currently covered by 10 analysts with an average price target of $516.48. This is a potential upside of $87.13 (20.29%) from yesterday's end of day stock price of $429.35.

Madrigal Pharmaceuticals's activity chart (see below) currently has 200 price targets and 145 ratings on display. The stock rating distribution of MDGL is 95.45% BUY and 4.55% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 88.74% with an average time for these price targets to be met of 458.44 days.

Highest price target for MDGL is $590, Lowest price target is $392, average price target is $490.4.

Most recent stock forecast was given by JAY OLSON from OPPENHEIMER on 09-Oct-2025. First documented stock forecast 28-Oct-2014.

Currently out of the existing stock ratings of MDGL, 21 are a BUY (95.45%), 1 are a HOLD (4.55%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$590

$160.65 (37.42%)

$400

3 days ago
(09-Oct-2025)

11/13 (84.62%)

$160.65 (37.42%)

350

Buy

$560

$130.65 (30.43%)

$460

14 days ago
(28-Sep-2025)

10/14 (71.43%)

$116.9 (26.38%)

261

Buy

$526

$96.65 (22.51%)

$428

1 months 1 days ago
(11-Sep-2025)

14/15 (93.33%)

$93.78 (21.70%)

378

Buy

$554

$124.65 (29.03%)

$390

1 months 17 days ago
(25-Aug-2025)

3/4 (75%)

$129.14 (30.40%)

277

Buy

$485

$55.65 (12.96%)

$443

1 months 23 days ago
(19-Aug-2025)

13/14 (92.86%)

$93.34 (23.83%)

409

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is MDGL (Madrigal Pharmaceuticals) average time for price targets to be met?

On average it took 458.44 days on average for the stock forecasts to be realized with a an average price target met ratio 88.74

Which analyst has the current highest performing score on MDGL (Madrigal Pharmaceuticals) with a proven track record?

JONATHAN WOLLEBEN

Which analyst has the most public recommendations on MDGL (Madrigal Pharmaceuticals)?

Jonathan Wolleben works at JMP and has 10 price targets and 8 ratings on MDGL

Which analyst is the currently most bullish on MDGL (Madrigal Pharmaceuticals)?

Jay Olson with highest potential upside - $160.65

Which analyst is the currently most reserved on MDGL (Madrigal Pharmaceuticals)?

Matthew Luchini with lowest potential downside - -$318.35

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?